Sturdy Memorial Hospital is a 128-bed community hospital in Southeastern Massachusetts. Under the leadership of its president and CEO, the hospital has launched two major capital projects, a $60 million cancer and specialty care building and a $112 million emergency department expansion. In 2025, Sturdy Health announced a transformative partnership with Boston-based Dana-Farber Cancer Institute, bringing world-class ambulatory cancer care, clinical trials and resources to the local region. The hospital has also introduced Mako robotic-arm assisted surgery to enhance orthopedic outcomes, and expanded its obstetric services during a time when many hospitals are scaling back on maternal health initiatives. The hospital’s quality and safety excellence is reflected in accolades such as an “A” from The Leapfrog Group, a Baby-Friendly designation, and multiple Healthgrades awards for stroke, pulmonary and critical care.
